After a blow out FQ4:18 quarterly show from Nvidia, RBC Capital’s Mitch Steves now spotlights 17% in return potential for the stock.
Aurinia potentially has the 1st treatment for lupus nephritis, says RBC Capital’s Douglas Miehm.
An article was published on Seeking Alpha detailing a long position.
Analyst sees a bright future on the horizon.
Two Strong Buy stocks in the e-commerce sector have just gotten stronger.
Oppenheimer’s Brian Bittner boosts his price target on SBUX stock ahead of the first quarterly print of the year.
Oppenheimer’s Jason Helfstein hikes up his 12-month price target 16% on Netflix following a stellar fourth quarter showcase.
Nomura’s Dan Dolev’s strong bullish call and price target jump on Square stock is sending shares rising 5% in trading today.
In reaction to acquisition buzz in the market’s grapevine, Maxim’s Jason McCarthy is out boosting his price target on Juno stock.
Susquehanna’s Christopher Rolland boosts his price target on QCOM stock on back of $1 billion cost reduction initiative.
